Biography

Greta E. Noland builds and manages global patent portfolios for clients in the biotechnology and pharmaceutical industries. As a component of her portfolio management, Ms. Noland represents clients in interference and appeal proceedings in the United States, and guides clients through opposition, appeal, conflict and revocation proceedings in other countries. She also frequently performs due diligence analyses for intellectual property transactions and public stock offerings. By virtue of working for academic, not-for-profit, private and public entities, her advice encompasses many perspectives important for product life cycle management. Ms. Noland achieves clients’ goals by delivering creative, attentive service molded by over twenty years of experience in the field.

Representative Experience

  • Prosecuting a U.S. accelerated examination application claiming methods of predicting development of a diabetic condition.
  • Defending an opposition against a European patent protecting the method of manufacture for a blockbuster cytokine product.
  • Completing due diligence analyses for a client’s acquisition of a FDA-approved bone graft product.

Ms. Noland has advanced clients’ rights in such technologies as:

  • Novel gene products including cellular adhesion molecules, chemokines, hormones, G proteins, phosphodiesterases, phosphatases and kinases
  • Therapeutic and diagnostic antibody products
  • Viral vectors and vaccines
  • Genetic engineering of plants
  • Gene regulation techniques
  • Diagnostic and prognostic methods

Education

  • Northwestern University (M.S.)
    • Molecular Biology
  • University of Notre Dame (B.S.)
    • Microbiology

Bar Admissions

  • U.S. Patent and Trademark Office

Background and Credentials

Ms. Noland was registered as a patent agent in 1991. Previously, she earned a B.S. in Microbiology from the University of Notre Dame and an M.S. in Molecular Biology from Northwestern University.

Representative Matters

Adams (Monsanto)* v. Leemans (Bayer Crop Sciences)
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Barton v. Fischhoff* (Monsanto) v. Adang (Mycogen Plant Science)
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Birkenbach v. Godiska (ICOS Corporation)*
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Conflict re: Kirin-Amgen, Inc.*
Canadian Intellectual Property Office
Case Type(s): Conflict
Area(s) of practice: Pharmaceuticals

Conflict re: Monsanto Company*
Canadian Intellectual Property Office
Case Type(s): Conflict
Area(s) of practice: Biotechnology

*Party Represented

Click here to see additional Representative Matters.